Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Incubation Period for Mad Cow Disease May Be 60 Years

By Biotechdaily staff writers
Posted on 07 Jul 2006
New findings show that the incubation period for variant Creutzfeldt-Jakob (vCJD) disease in humans, the human form of mad cow disease, may be much longer than supposed, perhaps as long as 60 years or more.

Researchers from the University College of London (UCL, UK) identified a prion disease called kuru among the people of New Guinea that occurred mainly in women and children who took part in funeral feasts that included the brains of relatives. More...
Boys older than eight customarily did not take part in these feasts.

The researchers took histories of residence and participation in funereal feasts and combined the information with data from serial neurologic examinations, when available. In all, they identified 11 patients, seven man and four women, with kuru. All of them were born before the practice of including brains in the funeral feasts was stopped in the 1950s. The researchers used experimental, epidemiologic, and human behavioral evidence to conclude that the practice had definitely stopped by 1960.

"Therefore, we could define the minimum incubation period as the time between 1960 and the date of onset of kuru,” wrote the researchers.

The seven patients were born between 1933 and 1949, and ranged from 46 to 62 years old at the time of disease onset. Based on all their data, the researchers determined that the minimum estimated incubation period ranged from 34-41 years. The incubation period in men who only took part in the funeral feasts when very young may have been 39-56 years or even 63 years, according to the investigators.

Eight of the 10 patients for whom genetic data were available were heterozygous for a polymorphism associated with extended incubation periods and resistance to prion diseases.

These findings suggest that an epidemic of variant CJD could show up many years from now, parallel with the aging of people who consumed beef from cows with bovine spongiform encephalopathy (BSE) back in the 1990s. The results were published in the June 24 issue of The Lancet.



Related Links:
University College, London

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.